Proteinase K Market, By Form (Lyophilized Powder Form, Liquid Form), By Application (Purification of DNA & RNA, In situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End User (Contract Research Organization, Academic Institutes, Biotechnology

Proteinase K Market, By Form (Lyophilized Powder Form, Liquid Form), By Application (Purification of DNA & RNA, In situ Hybridization, Mitochondria Isolation, Enzyme Removal), By End User (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Proteinase K is isolated from Engyodontium album fungus. It is capable of degrading several proteins in their native state. There are several applications of proteinase K such as mitochondria isolation, protein digestion for nucleic acid (DNA and RNA) purification, determination of enzyme localization on membranes, exposure of antigen binding sites on paraffin embedded tissue sections for antibody labeling, and several others. It is widely used in the purification of RNA and DNA tissues or cell lines.
Restraints of the Global Proteinase K Market
Factors such as availability of other protease enzymes, and chemicals is expected to restrain growth of the market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global proteinase K market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global proteinase K market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., F. Hoffmann-La Roche Ltd., New England Biolabs, Worthington Biochemical Corporation, Norgen Biotek Corp., BIORON GmbH, Sisco Research Laboratories Pvt. Ltd., Bioline (Meridian Biosciences Inc.), and Promega Corporation.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global proteinase K market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Proteinase K Market, By Form:
Lyophilized Powder Form
Liquid Form
Global Proteinase K Market, By Application:
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
Global Proteinase K Market, By End User:
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
Global Proteinase K Market, By Geography:
North America
By Form
Lyophilized Powder Form
Liquid Form
By Application
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
By End User
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
By Country:
U.S.
Canada
Europe
By Form
Lyophilized Powder Form
Liquid Form
By Application
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
By End User
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Form
Lyophilized Powder Form
Liquid Form
By Application
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
By End User
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Form
Lyophilized Powder Form
Liquid Form
By Application
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
By End User
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Form
Lyophilized Powder Form
Liquid Form
By Application
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
By End User
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
By Country:
GCC
Israel
Rest of Middle East
Africa
By Form
Lyophilized Powder Form
Liquid Form
By Application
Purification of DNA & RNA
In situ Hybridization
Mitochondria Isolation
Enzyme Removal
By End User
Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Thermo Fisher Scientific Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Merck KGaA
Qiagen N.V.
F. Hoffmann-La Roche Ltd.
New England Biolabs
Worthington Biochemical Corporation
Norgen Biotek Corp.
BIORON GmbH
Sisco Research Laboratories Pvt. Ltd.
Bioline (Meridian Biosciences Inc.)
Promega Corporation
“*” marked represents similar segmentation in other categories in the respective section.